Day-one level coverage
Every panel final expense application asks an “ever” question about HIV or AIDS; there is no lookback that clears it.
Health & coverage · HIV
We'll give you the straight answer most sites bury: every simplified-issue final expense carrier on our panel asks about HIV as an 'ever' question and declines on a yes — there's no graded tier and no waiting period. But two real doors exist: guaranteed-issue coverage that asks nothing, and a small fully-underwritten market that publishes criteria for well-controlled HIV. Here's both, honestly.
The honest landscape
On simplified-issue final expense, the answer is uniform: Mutual of Omaha, American Amicable, Transamerica, Foresters, Royal Neighbors, Liberty Bankers, and Accendo each ask whether you have ever been diagnosed with or tested positive for HIV or AIDS, and a yes ends eligibility for that product. Published drug charts flag antiretrovirals as no-coverage, so the prescription check catches it even if a question is missed. Banner’s fully underwritten term lists HIV as “most likely decline.” We won’t pretend otherwise.
The dependable door is guaranteed-issue whole life — no health questions, so nothing to fail. On our panel that’s Mutual of Omaha’s Guaranteed Whole Life (ages 45–85, $2,000–$25,000), Corebridge’s guaranteed-issue whole life (50–80, up to $25,000), and Americo’s Eagle Guaranteed (50–80). All carry a graded period: natural-cause death in the first two years (three at Americo) returns premiums plus interest; accidental death pays in full from day one; after that, the full benefit for life.
The second door is narrower but real: a handful of carriers outside our final-expense panel publish criteria for fully underwritten coverage — larger amounts, medical records and labs required — for people with well-controlled HIV. Pacific Life’s published bulletin (ages 20–65) requires at least a year of uninterrupted antiretroviral therapy, a stable CD4 count of 500 or higher, and an undetectable viral load for a year or more; Guardian’s published program (20–65) requires two or more years on therapy, CD4 above 350 and never below 200, no AIDS-defining illness, and care from an HIV specialist. These are referral situations for us — placement is entirely the carrier’s decision, and offers are typically rated above standard.
Your realistic paths
Every panel final expense application asks an “ever” question about HIV or AIDS; there is no lookback that clears it.
Carriers outside our panel publish criteria — years on therapy, CD4 and viral-load stability, no AIDS-defining illness. Larger coverage, medical underwriting, rated pricing. We can point you there; the carrier decides.
No health questions. Mutual of Omaha to 85, Corebridge and Americo to 80. Two-year graded period; accidental death covered in full from day one.
What moves the needle
Published criteria key on one to two-plus years of uninterrupted antiretroviral therapy with an undetectable viral load and stable CD4 — not on time since diagnosis alone.
Mutual of Omaha’s guaranteed product runs to 85; Corebridge and Americo stop at 80. Past 85, no guaranteed-issue product exists from any carrier we could verify.
Every application authorizes a prescription-history check; antiretrovirals are visible. A misstatement can void the policy in the contestability period — the outcome nobody wants.
Inside the application
Where the doors are
Every carrier draws its lines differently — these documented niches are why we shop your exact situation instead of accepting the first answer. Sources labeled; guidelines change without notice.
Guaranteed Whole Life: guaranteed acceptance ages 45–85, $2,000–$25,000, no exam and no health questions; natural-cause death in the first two years returns premiums plus 10%, accidental death pays in full.
Our full Mutual of Omaha reviewGuaranteed-issue whole life, ages 50–80, $5,000–$25,000, no health questions; years one and two return 110% of premiums for non-accidental death.
Our full AIG (Corebridge) reviewEagle Guaranteed, ages 50–80: no health questions, three-year graded schedule (premiums back plus interest in years one and two, 75% in year three, full from year four), accidental death paid in full throughout.
Our full Americo reviewPublished bulletin: fully underwritten coverage for ages 20–65 with a year or more of uninterrupted antiretroviral therapy, stable CD4 of 500+, undetectable viral load for a year or more, and no AIDS-defining illness; hepatitis B excluded.
Published program: ages 20–65, two or more years on therapy with favorable labs, CD4 above 350 and never below 200, undetectable viral load, no AIDS-defining condition, HIV-specialist care. Whole life and term at substantial face amounts.
Straight answers
Not from any final expense carrier on our panel — each asks an “ever” question about HIV or AIDS and declines on a yes, and there is no waiting period that clears it. Guaranteed-issue whole life is the dependable route: no health questions, ages 45–85 with Mutual of Omaha, with a two-year graded period for natural-cause death and full accidental coverage from day one.
Not for simplified-issue final expense — the question is “ever,” not “controlled.” It matters enormously in the fully underwritten market: carriers like Pacific Life and Guardian publish criteria built around years of uninterrupted therapy, sustained undetectable viral load, and stable CD4 counts, and they issue substantial coverage to applicants who meet them, typically at rated pricing. Those carriers are outside our final-expense panel; we can point you to that market, and the carrier makes the decision.
No — and we’d never help anyone do that. Every panel application includes an authorization to pull prescription and medical records, antiretrovirals are visible on every drug check, and a material misstatement can void the policy during the contestability period, leaving your family with nothing. Guaranteed-issue coverage exists precisely so that nobody has to lie to be insured.
One search, every door
A few basic questions — age, state, and your honest health picture — are exactly what lets us quote you accurately across the whole panel. A decline somewhere else is the start of our search, not the end. No exam to look, no spam, no pressure.